FR2810039B1 - Composes urees cycliques et leur procede de preparation - Google Patents

Composes urees cycliques et leur procede de preparation

Info

Publication number
FR2810039B1
FR2810039B1 FR0007507A FR0007507A FR2810039B1 FR 2810039 B1 FR2810039 B1 FR 2810039B1 FR 0007507 A FR0007507 A FR 0007507A FR 0007507 A FR0007507 A FR 0007507A FR 2810039 B1 FR2810039 B1 FR 2810039B1
Authority
FR
France
Prior art keywords
compounds
carbamic acid
new
function
urea compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0007507A
Other languages
English (en)
French (fr)
Other versions
FR2810039A1 (fr
Inventor
Gilles Guichard
Marc Rodriguez
Serge Plaue
Vincent Semetey
Arnaud Pierre Schaffner
Jean Paul Briand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0007507A priority Critical patent/FR2810039B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to JP2002510461A priority patent/JP5054877B2/ja
Priority to AU6764501A priority patent/AU6764501A/xx
Priority to AU2001267645A priority patent/AU2001267645B2/en
Priority to KR1020027016995A priority patent/KR20030031001A/ko
Priority to DE60132891T priority patent/DE60132891T2/de
Priority to ES01945420T priority patent/ES2301554T3/es
Priority to IL15340801A priority patent/IL153408A0/xx
Priority to EP01945420A priority patent/EP1289968B1/fr
Priority to EP05015015A priority patent/EP1640368A3/fr
Priority to PCT/FR2001/001837 priority patent/WO2001096318A1/fr
Priority to DK01945420T priority patent/DK1289968T3/da
Priority to CA2412782A priority patent/CA2412782C/en
Priority to US10/311,178 priority patent/US7186828B2/en
Priority to AT01945420T priority patent/ATE386728T1/de
Priority to CA2778314A priority patent/CA2778314C/en
Publication of FR2810039A1 publication Critical patent/FR2810039A1/fr
Application granted granted Critical
Publication of FR2810039B1 publication Critical patent/FR2810039B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/04—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR0007507A 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation Expired - Lifetime FR2810039B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR0007507A FR2810039B1 (fr) 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation
PCT/FR2001/001837 WO2001096318A1 (fr) 2000-06-13 2001-06-13 Composes urees cycliques et leur procede de preparation
AU2001267645A AU2001267645B2 (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
KR1020027016995A KR20030031001A (ko) 2000-06-13 2001-06-13 사이클릭 우레아 화합물 및 그의 제조방법
DE60132891T DE60132891T2 (de) 2000-06-13 2001-06-13 Zyklische harnstoffverbindungen und verfahren zu deren herstellung
ES01945420T ES2301554T3 (es) 2000-06-13 2001-06-13 Compuestos de ureas ciclicas y su procedimiento de preparacion.
IL15340801A IL153408A0 (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
EP01945420A EP1289968B1 (fr) 2000-06-13 2001-06-13 Composes urees cycliques et leur procede de preparation
JP2002510461A JP5054877B2 (ja) 2000-06-13 2001-06-13 環式尿素化合物及びその調製方法
AU6764501A AU6764501A (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
DK01945420T DK1289968T3 (da) 2000-06-13 2001-06-13 Cykliske urinstofforbindelser og fremgangsmåde til fremstilling heraf
CA2412782A CA2412782C (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
US10/311,178 US7186828B2 (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
AT01945420T ATE386728T1 (de) 2000-06-13 2001-06-13 Zyklische harnstoffverbindungen und verfahren zu deren herstellung
CA2778314A CA2778314C (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
EP05015015A EP1640368A3 (fr) 2000-06-13 2001-06-13 Composés urées cycliques et leur procédé de préparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007507A FR2810039B1 (fr) 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation

Publications (2)

Publication Number Publication Date
FR2810039A1 FR2810039A1 (fr) 2001-12-14
FR2810039B1 true FR2810039B1 (fr) 2007-05-25

Family

ID=8851208

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0007507A Expired - Lifetime FR2810039B1 (fr) 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation

Country Status (13)

Country Link
US (1) US7186828B2 (enExample)
EP (2) EP1640368A3 (enExample)
JP (1) JP5054877B2 (enExample)
KR (1) KR20030031001A (enExample)
AT (1) ATE386728T1 (enExample)
AU (2) AU6764501A (enExample)
CA (2) CA2778314C (enExample)
DE (1) DE60132891T2 (enExample)
DK (1) DK1289968T3 (enExample)
ES (1) ES2301554T3 (enExample)
FR (1) FR2810039B1 (enExample)
IL (1) IL153408A0 (enExample)
WO (1) WO2001096318A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7777030B2 (en) 2005-12-29 2010-08-17 Centre National de la Recherge Scientifique (CNRS) Compositions and methods for the treatment and prevention of disease
WO2007074169A2 (en) * 2005-12-29 2007-07-05 Immupharma France Sa Compositions and methods for the inhibition of phospholipase a2
EP1965806B1 (en) * 2005-12-29 2010-08-11 Immupharma France Sa 1, 3, 5-triazepin-2, 6-diones for the treatment of malaria
CA2635359A1 (en) * 2005-12-29 2007-07-05 Immupharma France Sa Compositions and methods for synthesizing heterocyclic therapeutic compounds
AU2006331357B2 (en) * 2005-12-29 2012-05-17 Immupharma France Sa Compositions and methods for synthesizing novel heterocyclic therapeutics
US8563115B2 (en) 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
EP2548869A1 (en) * 2011-07-20 2013-01-23 Cytec Technology Corp. Process for the Synthesis of N-substituted Cyclic Alkylene Ureas
CN102911130B (zh) * 2011-08-03 2015-05-20 北京师范大学 一种一锅法合成脲四元环化合物的方法、合成的脲四元环化合物
EP3466979B1 (en) 2013-08-21 2019-11-06 UREKA Sarl Peptide-oligourea chimeric compounds and methods of their use
WO2016207726A1 (en) 2015-06-22 2016-12-29 Ureka Sarl Bioinspired catalysis using oligourea helical foldamers
US10233213B2 (en) 2015-08-31 2019-03-19 Ureka Sarl Foldamer helix bundle-based molecular encapsulation
CN109328193A (zh) 2016-04-19 2019-02-12 尤瑞卡有限公司 肽-低聚脲折叠体化合物及其使用方法
US12434075B2 (en) * 2021-05-11 2025-10-07 Celestial Oncology Inc. Coupled robotic radiation therapy system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847760A1 (de) * 1978-11-03 1980-05-14 Hoechst Ag Verfahren zur herstellung von 1,3,5-triaza-2,4,6-triketo-cycloheptan- 3,5-di-essigsaeureestern
US4918186A (en) * 1986-05-06 1990-04-17 Mitsui Toatsu Chemicals, Inc. Process for producing cyclic ureas
EP0765873B1 (en) * 1991-10-11 2002-04-17 Dupont Pharmaceuticals Company Cyclic ureas and analogues useful as retroviral protease inhibitors
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5637780A (en) 1993-03-30 1997-06-10 The Dupont Merck Pharmaceutical Company Method for preparing alkylating agents and their use for alkylating cyclic ureas
US5508400A (en) * 1994-04-20 1996-04-16 The Du Pont Merck Pharmaceutical Company Preparation of cyclic urea compounds
WO1996029329A1 (en) * 1995-03-17 1996-09-26 The Du Pont Merck Pharmaceutical Company Cyclic urea hiv protease inhibitors
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
WO1997008150A1 (en) 1995-08-22 1997-03-06 The Du Pont Merck Pharmaceutical Company Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors
CN1235601A (zh) * 1996-11-08 1999-11-17 杜邦药品公司 (4R,5S,6S,7R)－六氢－1－[5－(3－氨基吲唑)甲基]－3－丁基－5,6－二羟基－4,7－双[苯甲基]－2H－1,3－二氮杂䓬－2－酮,它的制备及作为H<sub>2</sub>V蛋白酶抑制剂的应用

Also Published As

Publication number Publication date
JP2004503546A (ja) 2004-02-05
EP1289968B1 (fr) 2008-02-20
AU6764501A (en) 2001-12-24
ATE386728T1 (de) 2008-03-15
CA2778314C (en) 2017-01-03
ES2301554T3 (es) 2008-07-01
EP1640368A2 (fr) 2006-03-29
US7186828B2 (en) 2007-03-06
JP5054877B2 (ja) 2012-10-24
WO2001096318A1 (fr) 2001-12-20
IL153408A0 (en) 2003-07-06
EP1289968A1 (fr) 2003-03-12
EP1640368A3 (fr) 2007-03-28
WO2001096318A8 (fr) 2003-05-01
CA2412782A1 (en) 2001-12-20
DE60132891D1 (de) 2008-04-03
DK1289968T3 (da) 2008-06-23
KR20030031001A (ko) 2003-04-18
DE60132891T2 (de) 2009-03-19
CA2778314A1 (en) 2001-12-20
US20040044199A1 (en) 2004-03-04
FR2810039A1 (fr) 2001-12-14
AU2001267645B2 (en) 2006-07-27
CA2412782C (en) 2012-08-07

Similar Documents

Publication Publication Date Title
FR2810039B1 (fr) Composes urees cycliques et leur procede de preparation
CA2081970A1 (en) Hiv protease inhibitors useful for the treatment of aids
MY123740A (en) Il-13 receptor polypeptide
ATE293127T1 (de) Synthetische peptidinhibitoren der hiv- übertragung
EP1486207A3 (en) Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
ATE155486T1 (de) Zyklische peptide und ihre verwendung
CA2118812A1 (en) 5-ht4 receptor antagonists
ES2127189T3 (es) Peptido nuevo biologicamente activo procedente de una rana (rana-cpn).
CA2237189A1 (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
TR200000993T2 (tr) Endotelin antagonistleri.
DE3850550D1 (de) Dipeptide, verwendbar als Pflanzenwachstumsregulatoren.
BR0101230A (pt) Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina
WO1998010786A3 (en) Pharmaceutical composition for the treatment of syndrome x of reaven
CO4560412A1 (es) Piperidonas
AU682638B2 (en) Peptide, bronchodilator and blood flow ameliorant
CA2093202A1 (en) Sterilant gas mixture
EA200201003A1 (ru) Аморфная модификация торасемида
WO2001014576A3 (en) Process and intermediates for the preparation of isoxazolecaroxamides and analogues
SE9800865D0 (sv) New Process
ES2112921T3 (es) Peptidos y anticuerpos para el tratamiento de la artritis reumatoide.
CA2352893A1 (en) Substituted 1,3,5-triazines
NZ508812A (en) Peptides for the prevention or treatment of HIV
NZ506667A (en) A process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues
WO2004029081A3 (en) Modified glp-1 peptides with increased biological potency
NO952748D0 (no) Polypeptid som spesifikt inhiberer Cathepsin L.

Legal Events

Date Code Title Description
AU Other action affecting the ownership or exploitation of an industrial property right
CL Concession to grant licences
CD Change of name or company name
TQ Partial transmission of property
PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20